Initially, we discovered that CBX3 was substantially expressed in renal carcinoma, concerning a dismal prognosis—especially in high-grade (T3 + T4) ccRCC; these findings agreed with those of earlier research [31]. This evidence concerns the gene CBX3 and nonpapillary renal cell carcinoma.